EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 26 April 2024. Database contains 4821 unique substances/entries.
Filter the list
|
220-815-7
|
2905-69-3
|
Acute Tox. 4; STOT SE 3 |
|||
|
2-NITROBENZYLIDENE METHYL ESTER; BAY O 2787
|
400-650-9
|
39562-27-1
|
Skin Sens. 1 |
||
|
BM
|
405-270-7
|
39562-17-9
|
Skin Sens. 1 |
||
|
442-860-3
|
87333-22-0
|
Skin Sens. 1 |
|||
|
DISPERSE RED CLA 282
|
416-240-8
|
155522-12-6
|
Skin Sens. 1 |
||
|
JE 127
|
421-220-7
|
144740-59-0
|
Skin Sens. 1 |
||
|
LUGALVAN ES 9571
|
420-940-9
|
15768-07-7
|
Eye Irrit. 2; Skin Irrit. 2 |
||
|
443-120-2
|
393509-79-0
|
Eye Dam. 1 |
|||
|
MEFAT
|
404-130-2
|
105560-93-8
|
Eye Dam. 1; Skin Sens. 1 |
||
|
620-362-9
|
1918-18-9
|
Acute Tox. 4 |
|||
|
G 18-1108
|
403-270-1
|
6386-39-6
|
Acute Tox. 4 |
||
|
D,L-ESTER
|
411-040-7
|
97101-46-7
|
Acute Tox. 4; Skin Sens. 1 |
||
|
250-366-2
|
30864-28-9
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
431-720-7
|
90886-53-6
|
Skin Corr. 1B; Acute Tox. 4 |
|||
|
425-190-6
|
119916-05-1
|
STOT RE 2 |
|||
|
F7641; MTSI
|
410-550-7
|
79277-18-2
|
STOT RE 2; Resp. Sens. 1; Skin Sens. 1 |
||
|
A5546
|
402-050-2
|
59337-93-8
|
Skin Sens. 1 |
||
|
BROMBENZOAT; BROMOBENZOATE
|
410-310-1
|
70264-94-7
|
Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
||
|
MAT 9460
|
414-080-3
|
117291-73-3
|
Acute Tox. 4 |
||
|
201-185-2
|
79-20-9
|
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3 |
|||
|
203-299-8
|
105-45-3
|
Eye Irrit. 2 |
|||
|
MAGME(R) 200 MONOMER
|
403-230-3
|
77402-05-2
|
Carc. 1B; Muta. 1B; Skin Corr. 1B; Skin Sens. 1 |
||
|
MAGME 100 MONOMEER
|
401-890-7
|
77402-03-0
|
Carc. 1B; Muta. 1B; Acute Tox. 4; Eye Irrit. 2 |
||
|
202-500-6
|
96-33-3
|
Flam. Liq. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
202-501-1
|
96-34-4
|
Flam. Liq. 3; Acute Tox. 3; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
|||
|
201-187-3
|
79-22-1
|
Flam. Liq. 2; Acute Tox. 2; Acute Tox. 4; Skin Corr. 1B |
|||
|
203-481-7
|
107-31-3
|
Flam. Liq. 1; Acute Tox. 4; Eye Irrit. 2; STOT SE 3 |
|||
|
200-819-5
|
74-88-4
|
Carc. 2; Acute Tox. 4; Acute Tox. 3; STOT SE 3; Skin Irrit. 2 |
|||
|
210-866-3
|
624-83-9
|
Flam. Liq. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; Resp. Sens. 1; Skin Sens. 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
|||
|
209-132-5
|
556-61-6
|
Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
|||
|
201-297-1
|
80-62-6
|
Flam. Liq. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
FAT 40'489
|
413-040-2
|
149850-30-6
|
Skin Sens. 1 |
||
|
414-460-9
|
105726-67-8
|
Acute Tox. 4 |
|||
|
209-060-4
|
554-12-1
|
Flam. Liq. 2; Acute Tox. 4 |
|||
|
204-317-7
|
119-36-8
|
Repr. 2; Acute Tox. 4; Skin Sens. 1B |
|||
|
METHFAT
|
420-670-1
|
37443-42-8
|
Eye Dam. 1 |
||
|
203-475-4
|
107-25-5
|
Flam. Gas 1; Press. Gas |
|||
|
F5384
|
401-340-6
|
83055-99-6
|
Skin Sens. 1 |
||
|
236-035-5
|
13108-52-6
|
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
|||
|
N 5297
|
419-010-5
|
112941-26-1
|
Acute Tox. 4; Eye Irrit. 2 |
||
|
BETA-METHOXYACRYLSÄURE METHYLESTER
|
412-900-4
|
5788-17-0
|
Skin Sens. 1 |
||
|
435-500-1
|
152460-07-6
|
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
|||
|
209-765-7
|
592-62-1
|
Carc. 1B; Repr. 1B |
|||
|
246-910-3
|
25376-45-8
|
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1 |
|||
|
203-624-3
|
108-87-2
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
228-652-3
|
6317-18-6
|
Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
|||
|
247-714-0
|
26447-40-5
|
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
429-320-2
|
24748-23-0
|
Org. Perox. B; Asp. Tox. 1; Skin Irrit. 2; Skin Sens. 1 |
|||
|
200-471-4
|
60-34-4
|
Carc. 1B |
|||
|
204-064-2
|
115-09-3
|
Carc. 2; Repr. 1A; Lact.; Acute Tox. 2; STOT RE 1 |
|||